These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function. Liu CC; Zhao J; Fu Y; Inoue Y; Ren Y; Chen Y; Doss SV; Shue F; Jeevaratnam S; Bastea L; Wang N; Martens YA; Qiao W; Wang M; Zhao N; Jia L; Yamazaki Y; Yamazaki A; Rosenberg CL; Wang Z; Kong D; Li Z; Kuchenbecker LA; Trottier ZA; Felton L; Rogers J; Quicksall ZS; Linares C; Knight J; Chen Y; Kurti A; Kanekiyo T; Fryer JD; Asmann YW; Storz P; Wang X; Peng J; Zhang B; Kim BYS; Bu G Nat Neurosci; 2022 Aug; 25(8):1020-1033. PubMed ID: 35915180 [TBL] [Abstract][Full Text] [Related]
25. ERβ and ApoE isoforms interact to regulate BDNF-5-HT Chhibber A; Zhao L Alzheimers Res Ther; 2017 Sep; 9(1):79. PubMed ID: 28934977 [TBL] [Abstract][Full Text] [Related]
26. Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice. Pankiewicz JE; Guridi M; Kim J; Asuni AA; Sanchez S; Sullivan PM; Holtzman DM; Sadowski MJ Acta Neuropathol Commun; 2014 Jun; 2():75. PubMed ID: 24972680 [TBL] [Abstract][Full Text] [Related]
27. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging. Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682 [TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E ε4 disrupts oligodendrocyte differentiation by interfering with astrocyte-derived lipid transport. Mok KK; Yeung SH; Cheng GW; Ma IW; Lee RH; Herrup K; Tse KH J Neurochem; 2023 Apr; 165(1):55-75. PubMed ID: 36549843 [TBL] [Abstract][Full Text] [Related]
29. APOE genotype alters glial activation and loss of synaptic markers in mice. Zhu Y; Nwabuisi-Heath E; Dumanis SB; Tai LM; Yu C; Rebeck GW; LaDu MJ Glia; 2012 Apr; 60(4):559-69. PubMed ID: 22228589 [TBL] [Abstract][Full Text] [Related]
30. Distinct pro-inflammatory properties of myeloid cell-derived apolipoprotein E2 and E4 in atherosclerosis promotion. Igel E; Haller A; Wolfkiel PR; Orr-Asman M; Jaeschke A; Hui DY J Biol Chem; 2021 Sep; 297(3):101106. PubMed ID: 34425108 [TBL] [Abstract][Full Text] [Related]
31. The detrimental effects of APOE4 on risk for Alzheimer's disease may result from altered dendritic spine density, synaptic proteins, and estrogen receptor alpha. Taxier LR; Philippi SM; York JM; LaDu MJ; Frick KM Neurobiol Aging; 2022 Apr; 112():74-86. PubMed ID: 35051676 [TBL] [Abstract][Full Text] [Related]
32. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice. Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217 [TBL] [Abstract][Full Text] [Related]
33. Opposing Effects of ApoE2 and ApoE4 on Glycolytic Metabolism in Neuronal Aging Supports a Warburg Neuroprotective Cascade against Alzheimer's Disease. Zhang X; Wu L; Swerdlow RH; Zhao L Cells; 2023 Jan; 12(3):. PubMed ID: 36766752 [TBL] [Abstract][Full Text] [Related]
34. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention. Keeney JT; Ibrahimi S; Zhao L J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005 [TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology. Baum L; Chen L; Ng HK; Pang CP Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880 [TBL] [Abstract][Full Text] [Related]
36. Monomeric C-reactive protein induces the cellular pathology of Alzheimer's disease. Gan Q; Wong A; Zhang Z; Na H; Tian H; Tao Q; Rajab IM; Potempa LA; Qiu WQ Alzheimers Dement (N Y); 2022; 8(1):e12319. PubMed ID: 35846159 [TBL] [Abstract][Full Text] [Related]
37. Impact of APOE genotype on prion-type propagation of tauopathy. Williams T; Ruiz AJ; Ruiz AM; Vo Q; Tsering W; Xu G; McFarland K; Giasson BI; Sullivan P; Borchelt DR; Chakrabarty P Acta Neuropathol Commun; 2022 Apr; 10(1):57. PubMed ID: 35440098 [TBL] [Abstract][Full Text] [Related]
38. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128 [TBL] [Abstract][Full Text] [Related]
39. APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes. de Leeuw SM; Kirschner AWT; Lindner K; Rust R; Budny V; Wolski WE; Gavin AC; Nitsch RM; Tackenberg C Stem Cell Reports; 2022 Jan; 17(1):110-126. PubMed ID: 34919811 [TBL] [Abstract][Full Text] [Related]
40. The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease. Safieh M; Liraz O; Ovadia M; Michaelson D J Alzheimers Dis; 2024; 97(2):753-775. PubMed ID: 38217595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]